Paper83296
Evidence that L-rhamnose is the antigenic determinant of hyporesponsiveness of BALB/c mice to Klebsiella pneumoniae type 47.
White-Scharf ME and 1 other. Infect Immun, 1978. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Evidence that L-rhamnose is the antigenic determinant of hyporesponsiveness of BALB/c mice to Klebsiella pneumoniae type 47. Papers, record 83296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/83296
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evidence that L-rhamnose is the antigenic determinant of hyporesponsiveness of BALB/c mice to Klebsiella pneumoniae type 47.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Bacterial | Major topic |
| Antigens, Bacterial | Major topic |
| Klebsiella pneumoniae | Major topic |
| Polysaccharides, Bacterial | Major topic |
| Rhamnose | Major topic |
| Animals | |
| Cross Reactions | |
| Epitopes | |
| Mice | |
| Mice, Inbred BALB C | |
| Streptococcus pneumoniae |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,254,974 | The chromic chloride method of coupling antigens to erythrocytes: definition of some important parameters. | J Immunol Methods | 1976 | https://conductscience.org/library/papers/1254974 | PubMed |
| 2 | 14,181,467 | CHARACTERIZATION OF A GENETICALLY IDENTIFIABLE COMPONENT OF COMPLEMENT IN MICE. | Folia Microbiol (Praha) | 1964 | https://conductscience.org/library/papers/14181467 | PubMed |
| 3 | 4,403,476 | Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. | J Exp Med | 1972 | https://conductscience.org/library/papers/4403476 | PubMed |
| 4 | 830,786 | Genetic control of the immune response to staphylococcal nuclease. III. Time-course and correlation between the response to native nuclease and the response to its polypeptide fragments. | J Exp Med | 1977 | https://conductscience.org/library/papers/830786 | PubMed |
| 5 | 63,533 | Genetic control of the immune response to staphylococcal nuclease. IV. H-2-linked control of the relative proportions of antibodies produced to different determinants of native nuclease. | J Exp Med | 1977 | https://conductscience.org/library/papers/63533 | PubMed |
| 6 | 75,178 | The regulation of the immune response of mice to Haemophilus influenzae type b capsular polysaccharide. | Immunology | 1978 | https://conductscience.org/library/papers/75178 | PubMed |
| 7 | 5,839,284 | Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice. | J Exp Med | 1965 | https://conductscience.org/library/papers/5839284 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/83296
GET https://conductscience.org/api/papers/v1/83296/authors